Loading
A phase 1 trial of ADCX-020 run by Adcytherix SAS, now recruiting.
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers is a phase 1 interventional study registered as NCT07238075 by Adcytherix SAS, with 290 participants planned, started 2026-02-23. Conditions recorded: Advanced Malignancy, Advanced Solid Cancers and Metastatic Solid Tumors. Interventions recorded: ADCX-020.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/